市場調查報告書
商品編碼
1422697
低強度甜味劑市場規模-依產品類型(赤藻醣醇、麥芽糖醇、木糖醇、DTagatose、山梨醇、甘露糖醇、阿洛酮糖)、來源(天然、合成)、應用(食品和飲料、藥品、個人護理)和全球預測,2024-2032Low Intensity Sweeteners Market Size-By Product Type (Erythritol, Maltitol, Xylitol, DTagatose, Sorbitol, Mannitol, Allulose), Source (Natural, Synthetic), Application (Food & Beverages, Pharmaceuticals, Personal Care) & Global Forecast, 2024-2032 |
在食品技術進步以及食品和飲料配方減糖趨勢的推動下,2024年至2032年全球低強度甜味劑市場CAGR將達到4.7%。隨著消費者越來越重視健康,製造商正在利用創新的解決方案來滿足對低熱量替代品的需求。尖端食品技術的整合使得能夠開發出有吸引力的低糖產品。技術進步與人們普遍追求更健康的選擇之間的協同作用將極大地促進市場成長。
該公司正在積極開發低熱量糖替代品並推出新產品,從而擴大市場佔有率。例如,2023 年,Tate & Lyle Sugars 將三氯蔗糖涵蓋其甜味劑系列。這一添加提供了蔗糖 70% 的甜度,滿足了對低熱量糖替代品不斷成長的需求。
低強度甜味劑產業根據產品、應用和地區進行分類。
由於山梨醇的多功能性和天然來源,到 2032 年,山梨醇細分市場將獲得顯著成長,使其成為尋求低熱量選擇的注重健康的消費者的首選。山梨糖醇能夠複製糖的甜味,而不會產生相關的熱量影響,因此滿足了對更健康甜味替代品不斷成長的需求。山梨醇細分市場的主導地位凸顯了其在滿足消費者和更廣泛的食品和飲料行業不斷變化的偏好方面的關鍵作用。
到2032 年,製藥領域的低強度甜味劑市場規模將大幅成長。隨著注重健康的消費者擴大尋求糖替代品,製藥業在各種配方中使用低強度甜味劑有助於實現這一主導地位。製藥業專注於創造美味的藥物和補充劑,正在推動對這些甜味劑的需求。它們在增強口服藥物的味道同時最大限度地減少熱量攝取方面發揮著重要作用,使製藥業成為不斷擴大的低強度甜味劑市場的重要參與者。
在消費者健康意識增強的推動下,歐洲低強度甜味劑產業將在 2024 年至 2032 年呈現顯著的複合CAGR,促使人們轉向低糖替代品。對食品和飲料中糖含量的嚴格監管進一步刺激了該地區對低強度甜味劑的需求。作為這一市場趨勢的重要貢獻者,歐洲反映出更健康的甜味劑選擇在食品和飲料行業中日益重要。
Global Low Intensity Sweeteners Market will register a 4.7% CAGR from 2024 to 2032, propelled by advancements in food technology and the surging trend of sugar reduction in food and beverage formulations. As consumers increasingly prioritize health, manufacturers are leveraging innovative solutions to meet the demand for low-calorie alternatives. The integration of cutting-edge food technology enables the development of appealing products with reduced sugar content. This synergy between technological advancements and the prevalent drive toward healthier choices will contribute significantly to the market growth.
Companies are actively formulating low-calorie sugar substitutes and introducing new product offerings, thus strengthening their market share. For instance, in 2023, Tate & Lyle Sugars incorporated sucralose into its range of sweeteners. This addition, offering 70% of the sweetness of sucrose, caters to the growing demand for low-calorie sugar alternatives.
The low intensity sweeteners industry is classified based on product, application, and region.
The sorbitol segment will garner remarkable gains by 2032, attributed to sorbitol's versatility and natural origin, making it a preferred choice for health-conscious consumers seeking reduced-calorie options. With the ability to replicate sugar's sweetness without the associated caloric impact, sorbitol aligns with the rising demand for healthier sweetening alternatives. The dominance of the sorbitol segment underscores its pivotal role in meeting the evolving preferences of consumers and the broader food and beverage industry.
The low intensity sweeteners market size from the pharmaceuticals segment will witness a substantial upswing by 2032. As health-conscious consumers increasingly seek sugar alternatives, the pharmaceutical industry's utilization of low-intensity sweeteners in various formulations contributes to this dominance. With an emphasis on creating palatable medications and supplements, the pharmaceutical segment is driving demand for these sweeteners. Their role in enhancing the taste of oral medications while minimizing caloric intake positions the pharmaceuticals segment as a significant player in the expanding low intensity sweeteners market.
Europe low intensity sweeteners industry will demonstrate a significant CAGR from 2024 to 2032, driven by heightened consumer awareness of health and wellness, prompting a shift toward reduced-sugar alternatives. Stringent regulations on sugar content in food and beverages further boost the demand for low-intensity sweeteners in the region. As a significant contributor to this market trend, Europe reflects the growing importance of healthier sweetening options in the food and beverage industry.